Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

B cells may play a role in triggering immunotherapy-related colitis

18

Sep 2026

B cells may play a role in triggering immunotherapy-related colitis

Researchers at The University of Texas MD Anderson Cancer Center have identified a previously unknown role for B cells, which are adaptive immune cells, in triggering and sustaining colitis occurring as a side effect of immune checkpoint inhibitors, a widely used form of cancer immunotherapy.

Salivary cortisol patterns predict cognitive decline in older adults

18

Sep 2026

Salivary cortisol patterns predict cognitive decline in older adults

An irregular pattern and consistently higher levels of a stress hormone called cortisol found in the saliva were associated with cognitive decline later in life - Blacks specifically had lower overall cortisol levels and less change in their levels during the day than whites - according to newly published research.

New white paper calls for integrating oral and general healthcare

18

Sep 2026

New white paper calls for integrating oral and general healthcare

Oral health can no longer be treated separately from general health, according to a new white paper from the European Federation of Periodontology (EFP) and the European Association of Dental Public Health (EADPH) which calls for closer collaboration between dental, medical, public-health and social-care professionals.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.